Best Cholangiocarcinoma (Bile Duct Cancer) Treatment Hospitals Worldwide

At Aster Medcity, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 2013, the NABH, JCI accredited hospital is located in Kochi, India, and has 670 beds.

Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.

Medicana Camlica Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 1999, the ISO, JCI accredited hospital is situated in Istanbul, Turkey, with 113 beds, serving local and international patients.

Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.

Aakash Healthcare Super Speciality Hospital offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 2011, the NABH, ISO accredited hospital is located in Delhi, India, with 230 beds, providing comprehensive cancer care for local and international patients.

Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.

Memorial Sisli Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 2000, the JCI, NABH accredited hospital is situated in Istanbul, Turkey, with 252 beds, serving local and international patients.

Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.

At Hisar Intercontinental Hospital, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 2005, the JCI accredited hospital is located in Istanbul, Turkey, and has 170 beds.

Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.

With advanced hepatobiliary oncology infrastructure, NMC Specialty Hospital, Al Nahda offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 2004, the JCI accredited hospital is located in Dubai, United Arab Emirates, and has 187 beds.

For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.

NMC Specialty Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1975, the JCI, NABH accredited hospital is based in Abu Dhabi, United Arab Emirates, with 104 beds and services for domestic and international patients.

The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.

Thumbay University Hospital, Ajman provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2002, the JCI accredited hospital is based in Ajman, United Arab Emirates, with 350 beds and services for domestic and international patients.

The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.

HE Clinic provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2013, the NABH accredited hospital is based in Bangkok, Thailand, with beds and services for domestic and international patients.

The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.

With advanced hepatobiliary oncology infrastructure, Lokman Hekim Esnaf Hospital offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 1997, the JCI accredited hospital is located in Fethiye, Turkey, and has 75 beds.

For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.

Bukit Tinggi Medical Centre offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 2016, the MSQH accredited hospital is situated in Kuala Lumpur, Malaysia, with 171 beds, serving local and international patients.

Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.

Fortis Hiranandani Hospital offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 2007, the NABH accredited hospital is located in Mumbai, India, with 149 beds, providing comprehensive cancer care for local and international patients.

Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.

Jaypee Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 2014, the NABH, JCI accredited hospital is situated in Noida, India, with 1200 beds, serving local and international patients.

Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.

Wockhardt Hospital - A new Age Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 2014, the NABH, NABL, JCI accredited hospital is situated in Mumbai, India, with 350 beds, serving local and international patients.

Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.

Seven Hills Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1986, the NABH, NABL, JCI accredited hospital is based in Mumbai, India, with 1500 beds and services for domestic and international patients.

The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.